| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2004 | CN1518985A A group of medication compsn. for treating acne |
| 08/11/2004 | CN1518984A Preparation of non-intestinal tract administration Adefovir and Adefovir Dipivixi |
| 08/11/2004 | CN1518983A Coordinated modication combination for anti hepatitis B virus |
| 08/11/2004 | CN1518982A Active component of muskrat fragrant, preparing technique and usage |
| 08/11/2004 | CN1518981A External eye drip preparation for treating short sight |
| 08/11/2004 | CN1518980A Method for preparing liquor pharmaceutics containing alendazole sulfoxide |
| 08/11/2004 | CN1518979A oral liquor pharmaceutics containing albendazole sulfoxide for animal use |
| 08/11/2004 | CN1518978A Mouth cavity spraying agent containing benzimidazole family for expelling worms |
| 08/11/2004 | CN1518977A Combination of levogyrate bicalutamide |
| 08/11/2004 | CN1518976A Externally used pharmaceutics for treating colpitis mycotica |
| 08/11/2004 | CN1518975A External use pharmaceutics in simple recipe and compound recipe for treating mycosis ungualis (tinea auguium, onychomycosis) |
| 08/11/2004 | CN1518974A Chawing tablet containing beta carotene |
| 08/11/2004 | CN1161614C Corticotropin releasing factor receptor-1 deficient mice, and method of dertermination agonist agent and antagonist |
| 08/11/2004 | CN1161396C Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 08/11/2004 | CN1161395C Polymer comprising unsaturated ester units and pharmaceutical and comsetic compositions thereof |
| 08/11/2004 | CN1161389C Preparing process and use of ginkgo leaf polypentenol and ginkgo leaf extract |
| 08/11/2004 | CN1161369C Improved process for antiparasitic agent |
| 08/11/2004 | CN1161363C Diphosphonic acid salts for treatment of osteoporsis |
| 08/11/2004 | CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161355C New compounds |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161351C Novel form of S-omeprazole |
| 08/11/2004 | CN1161350C Method for the preparation of citalopram |
| 08/11/2004 | CN1161345C 1,5-benzodiazepine derivatives ad CCK-A receptor agonists |
| 08/11/2004 | CN1161341C Fused pydiopyridazine inhibitors of cGMP phosphodiesterase |
| 08/11/2004 | CN1161340C Benzimidazole compounds that are vitronectin receptor antagoninsts |
| 08/11/2004 | CN1161339C Pyrazoles derivs., Pharmaceutical salt thereof and composition contg. same |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161336C Quinolinecarboxamides as antiviral agents |
| 08/11/2004 | CN1161333C Oxindole derivatives as growth hormone releasers |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/11/2004 | CN1161314C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxyl] ethanol and pharmaceutical compositions thereof |
| 08/11/2004 | CN1161156C The use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability |
| 08/11/2004 | CN1161143C Drop pills for toothache and its prepn. tech |
| 08/11/2004 | CN1161142C Medicinal composition for improving memory |
| 08/11/2004 | CN1161139C External use traditional Chinese medicine preparation for curing scald by fire or water and its preparing method |
| 08/11/2004 | CN1161133C Liposoluble Chinese medicine rectal suppository for treating acute and chronic prostatitis |
| 08/11/2004 | CN1161128C Anigiogenic inhibitory compounds |
| 08/11/2004 | CN1161126C Composition for preparing medicines, beautifying and cosmetics and its application |
| 08/11/2004 | CN1161125C Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 08/11/2004 | CN1161124C Sulfacted oilgosacharides having anticoagulant/antithrombotic activity |
| 08/11/2004 | CN1161123C Method for producing water dispersible sterol formualtions |
| 08/11/2004 | CN1161122C Novel Composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 08/11/2004 | CN1161121C Alkaloid of matrine category utilized for mainline and its preparation method |
| 08/11/2004 | CN1161120C Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylasis treatment of obesity |
| 08/11/2004 | CN1161119C Lefunomide plaster and its prepn. method |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161117C Medicinal compositions |
| 08/11/2004 | CN1161116C Use of L-Carnitine and derviatives for reducing ceramide levels and potentiating antiretroviral |
| 08/11/2004 | CN1161115C Inclusion complex |
| 08/11/2004 | CN1161114C Usage of compound in pharmaceutic mfg. for treating sleep apnoea |
| 08/11/2004 | CN1161113C Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 08/11/2004 | CN1161112C Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161109C Fluoxetine enteric micropills |
| 08/11/2004 | CN1161108C Method for preparing pills containing 90 wt.% activated pharmaceutical compositions |
| 08/11/2004 | CN1161107C Oral formulation for gastrointestinal drug delivery |
| 08/11/2004 | CN1161104C Pharmaceutical formulations for aerosols with two or more active substances |
| 08/11/2004 | CN1161103C Perfusate preparation for ophthalmic operation |
| 08/11/2004 | CN1161102C Topical hormonal composition with systemic effect |
| 08/11/2004 | CN1161100C Topical compositions having improved skin feel |
| 08/11/2004 | CN1161099C Composition for topical delivery of active ingredients |
| 08/11/2004 | CN1161097C Method and composition for causing skin lightening |
| 08/11/2004 | CN1161087C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 08/11/2004 | CN1161036C Compsns. containing creatine in suspension |
| 08/11/2004 | CN1161035C Process for preparing additive of food, medicines, or cosmetics to supplement linoleic acid and alpha-linoleic acid |
| 08/11/2004 | CN1161018C Composition for keeping away vermin |
| 08/10/2004 | US6774247 Aqueous solution of ascorbic acid and method for producing same |
| 08/10/2004 | US6774241 Ht3 receptor antagonists for nervous system, psychological, eating, and sleep disorder treatment |
| 08/10/2004 | US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
| 08/10/2004 | US6774235 Trisubstituted 1,3,5-triazine derivatives |
| 08/10/2004 | US6774231 Bactericides |
| 08/10/2004 | US6774230 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants |
| 08/10/2004 | US6774228 1,4,7,10-tetrazacyclododecanes capable of reacting with monoclonal or polyclonal antibody; imaging |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774145 Solvent extraction using methanol, ethanol, ethyl acetate, acetonitrile, acetone, and aqueous solution; distillation, chromatography; recovering dibenzofuran derivative antioxidant from seaweed |
| 08/10/2004 | US6774144 Administering alkylenebis(2-benzimidazole), dibenzofuran, dibenzothiophene, carbazole, pyrimidine, or 2,4-diphenylfuran derivative as vaccine; veterinary medicine; poultry, birds |
| 08/10/2004 | US6774143 Treating multidrug resistant cancer cells with discodermolide to limit growth of unregulated cells having tubulin mutations and promoting phosphorylation of raf oncogene; administering antitumor and anticarcinogenic agents |
| 08/10/2004 | US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative. |
| 08/10/2004 | US6774140 Antiarthritic agents |
| 08/10/2004 | US6774139 Contraceptives |
| 08/10/2004 | US6774137 For therapy of temporary prevention of itching of the eye due to allergic conjunctivitis |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774135 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease |
| 08/10/2004 | US6774134 For therapy of respiratory syncytial virus infection |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774131 Prostate cancer |
| 08/10/2004 | US6774130 Treating chronic inflammatory disease, chronic intestinal inflammation, arthritis, psoriasis, asthma and autoimmune disorders; th1 cell-mediated disorders; for example, 1,2,3,6-tetrahydro-7h-purine-2,6-dione derivatives |
| 08/10/2004 | US6774129 Alpha 2-adrenoceptor antagonists; antidepressants and treating parkinson's disease |
| 08/10/2004 | US6774128 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (no) activity as measured in a standard gastric emptying assay |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774125 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 08/10/2004 | US6774124 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 08/10/2004 | US6774123 Methods and compositions for inactivating viruses |
| 08/10/2004 | US6774122 Sustained release; injection of fulvestrant |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |